Ask questions and gain insights about this stock now with Rize AI
EW logo

Edwards Lifesciences Corporation

EW

Stock Analysis

$78.21

+0.00 (+0.00%)• Live

Edwards Lifesciences Corporation Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Edwards Lifesciences Corporation

Key Financial Metrics

for Edwards Lifesciences Corporation

2024 FY
P/E Ratio
10.59
Revenue Growth
-9.41%
EPS Growth
+202.16%
Market Cap
$44.27B
Dividend Yield
0.00%
Debt/Equity
0.07
ROIC
+11.40%
FCF Yield
+0.65%
View additional metrics

Valuation

P/B Ratio4.43
EV/Sales7.57

Financial Health

Current Ratio4.18
Return on Assets+41.38%

Analyst Recommendations

for Edwards Lifesciences Corporation

48 analysts
Consensus: Buy

About

for Edwards Lifesciences Corporation

Company Details

for Edwards Lifesciences Corporation

Sector

Healthcare

Industry

Medical - Devices

CEO

Bernard J. Zovighian

Employees

15,800

Market Cap

45.88B

Exchange

New York Stock Exchange

IPO Date

March 27, 2000

CIK

0001099800

ISIN

US28176E1082

CUSIP

28176E108

Country

US

Balance Sheet

for Edwards Lifesciences Corporation

Cash Flow Statement

for Edwards Lifesciences Corporation

Income Statement

for Edwards Lifesciences Corporation

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.